Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |